clinical trial · NCT03069326
A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis
MyelofibrosisRuxolitinibThalidomide
brief summary
The purpose of this study is to test any good and bad effects of the study drugs called ruxolitinib and thalidomide. Ruxolitinib and thalidomide could shrink the cancer, but it could also cause side effects.
started
Feb 27, 2017
primary completion
Feb 1, 2027
completion
Feb 1, 2027
last updated
Apr 13, 2026
official title
Evaluation of Ruxolitinib And Thalidomide Combination as a Therapy for Patients With Myelofibrosis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol